DEXCOM INC Executive Compensation
Named executive officer pay as disclosed in the company’s 2026-04-15 proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.
$7,985,960
Jacob Leach, Chief Executive Officer — total compensation
Healthcare
industry
| Executive | Title | Base salary | Total compensation |
|---|---|---|---|
| Kevin Sayer | Executive Chairman | — | $16,282,598 |
| Jacob Leach | President & Chief Executive Officer | — | $7,985,960 |
| Jereme Sylvain | EVP, Chief Financial Officer | — | $7,077,902 |
| Jon Coleman | EVP, Chief Commercial Officer | — | $6,745,295 |
| Michael Brown | EVP, Chief Legal Officer | — | $6,343,856 |
| Sadie Stern | EVP, Chief Human Resources Officer | — | $6,253,131 |
Source: DEXCOM INC Definitive Proxy Statement (DEF 14A), filed 2026-04-15 with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.
Other Healthcare companies
UNITEDHEALTH GROUP INC
Healthcare
$60,938,062
Stephen Hemsley, CEO
ELI LILLY & Co
Healthcare
$36,698,337
David A. Ricks, CEO
JOHNSON & JOHNSON
Healthcare
$32,758,111
J. Duato, CEO
AbbVie Inc.
Healthcare
$32,530,984
Robert A. Michael, CEO
GILEAD SCIENCES, INC.
Healthcare
$28,437,198
Daniel P, CEO
PFIZER INC
Healthcare
$27,585,301
A. Bourla, CEO
